ABOUT US
In February 2021 @ Copenhagen Denmark Synobody (then ImmuNordic) was founded by Emil Arvedsen, PhD, and Jannik Faliu, MSc, in the hopes of minimizing the gap and break down barriers between researchers and nanobody immunolabeling.
The Synobody team is driven by a passion for creating a self sustained company with an impact on global research.
MEET THE TEAM
Who’s Who
Want to meet a member of our incredible team? Give us a call.